Can GLP-1s Change the Way Food Tastes?

CC Exclusive Analysis

A new study published in Diabetes, Obesity and Metabolism suggests that popular GLP-1 medications (like Ozempic, Wegovy, and Mounjaro) may alter patients’ perception of taste, contributing to their weight management effects.

Key Study Findings

• Taste Changes: About one-fifth of participants reported that food tasted either sweeter (21.3%) or saltier (22.6%) after starting GLP-1 treatment. No significant changes were reported for bitterness or sourness.
• Appetite and Cravings: In line with the known effects of the drugs:
  • Over half of participants reported a decreased appetite.
  • Almost two-thirds reported increased satiety (feeling fuller sooner).
  • Participants across all groups reported reduced food cravings, with the Mounjaro group reporting the highest reduction (41.3%).
• Taste-Appetite Connection: The study found a strong link between these taste shifts and the drugs’ impact on eating behavior:
  • Those who reported food tasting sweeter were about twice as likely to report increased satiety and significantly more likely to report reduced appetite and cravings.
  • Those who reported food tasting saltier were also about twice as likely to report increased satiety.
• No Direct BMI Link: The study did not find an association between changes in taste perception and the amount of BMI reduction. The researchers noted that taste is only one factor influencing weight loss, which is also dependent on metabolism, long-term eating patterns, and activity.

In summary, the study suggests that GLP-1 drugs don’t just reduce appetite directly, but may also work by changing the appeal or satisfaction of food via an altered sense of taste, though this taste change alone is not enough to directly predict overall weight loss.

Read more here: https://www.advisory.com/daily-briefing/2025/10/08/glp-1-taste